TrialDiabetes care2013

Favorable effects of insulin sensitizers pertinent to peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Andrew D Althouse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.